Fibroblasts are an integral constituent of the connective tissue compartment (the """"""""interstitium"""""""") of the kidney - just like in any other parenchymal organ. While fibroblasts in the kidney are unanimously considered main mediators of chronic fibrogenesis, the pathological process that underlies chronic renal failure, little is known about the physiological role of renal fibroblasts. Our preliminary studies demonstrate that fibroblasts are also important mediators of spontaneous repair of acute kidney injury - in striking contrast to their detrimental role in kidney fibrosis. This raises the questions of 1) how fibroblasts contribute to repair of acute renal injury? and of 2) what the molecular mechanisms are that turn a """"""""good"""""""" fibroblast into a """"""""bad"""""""" fibroblast ? While the long-term goal of our laboratory is to elucidate the molecular mechanisms switch that turn beneficial fibroblasts into detrimental fibroblasts, experiments proposed in this application will elucidate how fibroblasts contribute to repair of acute renal injury, and specifically the role of FGF4 in this process. In our preliminary studies, we performed global gene expression profiling on FACS-sorted fibroblasts from control kidneys and kidneys after ischemia-reperfusion injury and we identified fibroblast growth factor 4 (FGF4) to be specifically expressed in fibroblasts in acute injury and not in normal kidney (and also not in fibrotic kidneys). Based on our preliminary studies, the central hypothesis of this application is that the beneficial role of renal fibroblasts in repair of acute injury in the kidney is dependent on FGF4.

Public Health Relevance

The kidney possesses a unique capacity to repair itself from acute injury. However, pathological repair of the kidney, which is referred to as """"""""fibrogenesis"""""""" destructs the kidney architecture and causes kidney failure. The main mediators of such fibrosis are fibroblasts. Our preliminary studies suggest that fibroblasts - which are detrimental in kidney fibrosis, are required for repair of acute injury. Experiments proposed in this application are designed to gain insights into what turns a """"""""good"""""""" fibroblast into a """"""""bad"""""""" fibroblast.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Small Research Grants (R03)
Project #
5R03DK081687-02
Application #
7670356
Study Section
Diabetes, Endocrinology and Metabolic Diseases B Subcommittee (DDK)
Program Officer
Rankin, Tracy L
Project Start
2008-08-15
Project End
2010-07-31
Budget Start
2009-08-01
Budget End
2010-07-31
Support Year
2
Fiscal Year
2009
Total Cost
$72,250
Indirect Cost
Name
Beth Israel Deaconess Medical Center
Department
Type
DUNS #
071723621
City
Boston
State
MA
Country
United States
Zip Code
02215
O'Connell, Joyce T; Sugimoto, Hikaru; Cooke, Vesselina G et al. (2011) VEGF-A and Tenascin-C produced by S100A4+ stromal cells are important for metastatic colonization. Proc Natl Acad Sci U S A 108:16002-7
Bechtel, Wibke; McGoohan, Scott; Zeisberg, Elisabeth M et al. (2010) Methylation determines fibroblast activation and fibrogenesis in the kidney. Nat Med 16:544-50
Flier, Sarah N; Tanjore, Harikrishna; Kokkotou, Efi G et al. (2010) Identification of epithelial to mesenchymal transition as a novel source of fibroblasts in intestinal fibrosis. J Biol Chem 285:20202-12
Zeisberg, Michael; Duffield, Jeremy S (2010) Resolved: EMT produces fibroblasts in the kidney. J Am Soc Nephrol 21:1247-53
Zeisberg, Michael; Neilson, Eric G (2009) Biomarkers for epithelial-mesenchymal transitions. J Clin Invest 119:1429-37